Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by pmartino
Group name EquipePM
Item Type Journal Article
Title An in-line enzymatic microreactor for the middle-up analysis of monoclonal antibodies by capillary electrophoresis
Creator Dadouch et al.
Author Meriem Dadouch
Author Yoann Ladner
Author Claudia Bich
Author Marion Larroque
Author Christian Larroque
Author Jacques Morel
Author Pierre-Antoine Bonnet
Author Catherine Perrin
Abstract Monoclonal antibodies (mAbs) are undergoing rapid growth in the pharmaceutical industry due to their clinical efficiency. Concomitantly, robust, cost-effective, and high throughput analytical methods are needed for their quality control. Among all analytical techniques, capillary electrophoresis (CE) presents alternative and attractive features because the capillary can be used both as a microreactor and as a support for separation. Transverse diffusion of laminar flow profiles was applied for the middle-up analysis of mAbs for the first time. Infliximab was selected as the model mAb. All middle-up analysis steps (enzymatic digestion, electrophoretic separation and UV detection) were integrated into the same capillary. The conditions for the separation of infliximab subunits (pH, ionic strength, and type of background electrolyte) and in-line digestion parameters (reactant injection conditions, time, temperature and enzyme/mAb ratio) were optimized. The in-line methodology was compared to the off-line methodology and evaluated in terms of proteolysis efficiency, repeatability, and applicability to different mAbs. Finally, the methodology was transferred to capillary electrophoresis coupled to mass spectrometry (sheathless interface) to identify infliximab subunits. The in-line methodology was successfully implemented with a simplified injection scheme, temperature control, fast enzymatic reaction and high resolution of separation of infliximab subunits under pseudo-native MS compatible conditions. In comparison with the off-line methodology, reactant consumption was reduced by a factor of 1000, and the numbers of theoretical plates were increased by a factor of 2.
Publication The Analyst
Date Jan 08, 2020
Journal Abbr Analyst
Language eng
DOI 10.1039/c9an01906e
ISSN 1364-5528
Library Catalog PubMed
Extra 00000 PMID: 31913378
Tags original
Date Added 2020/02/07 - 08:23:57
Date Modified 2021/03/05 - 10:42:44
Notes and Attachments PubMed entry (Attachment)
PubMed entry (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés